Trading Signals: SGEN Stock Price Prediction and Forecast (Fri. May. 30, 2003 - Wed. Dec. 13, 2023)(Seattle Genetics, Inc.)
| SGEN latest price $121.0200 (0.38%) ($119.4800 - $121.5300) on Wed. Nov. 27, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.94% (three month average) | RSI | 89 | Latest Price | $121.0200(0.38%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SGEN advances 5.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support SGEN advance at 0% a week (0% probability) XLC(34%) IYT(25%) VFMO(24%) BOTZ(23%) DIA(23%) | Factors Impacting SGEN price | SGEN will decline at least -1.47% in a week (0% probabilities). VIXM(-12%) VXX(-5%) TLT(-1%) UUP(0%) IGOV(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.47% (StdDev 2.94%) | Hourly BBV | 0 () | Intraday Trend | 0.3% | | | |
|
5 Day Moving Average | $120.38(0.53%) | 10 Day Moving Average | $118.6(2.04%) | 20 Day Moving Average | $113.49(6.63%) | To recent high | -0.5% | To recent low | 78.5% | Market Cap | $21.041b | | | | Seattle Genetics, Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. |